These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 4691105

  • 1. Nonbacterial pneumonitis with multidrug antineoplastic therapy in breast carcinoma.
    Stutz FH, Tormey DC, Blom J.
    Can Med Assoc J; 1973 Mar 17; 108(6):710-4. PubMed ID: 4691105
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT, Palshof T.
    Prog Clin Biol Res; 1977 Jan 01; 12():459-66. PubMed ID: 335404
    [No Abstract] [Full Text] [Related]

  • 4. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV, Murphy S, Huguley CM, Bartolucci AA.
    Cancer Res; 1976 Nov 01; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA, Grillo-López A, Vélez-Garciá E.
    Bol Asoc Med P R; 1975 Jun 01; 67(6):157-63. PubMed ID: 1055588
    [No Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy in the treatment of advanced breast cancer.
    Rosner D, Nemoto T, Dao TL.
    J Surg Oncol; 1976 Jun 01; 8(6):465-9. PubMed ID: 994508
    [Abstract] [Full Text] [Related]

  • 7. Disseminated breast carcinoma. Treatment with combination chemotherapy.
    Spigel SC, Coltman CA, Costanzi JJ.
    Arch Intern Med; 1973 Oct 01; 132(4):575-7. PubMed ID: 4742410
    [No Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy in advanced breast cancer.: a randomized trial comparing a three-vs a five-drug program.
    Muss HB, White DR, Cooper MR, Richards F, Spurr CL.
    Arch Intern Med; 1977 Dec 01; 137(12):1711-4. PubMed ID: 337916
    [Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH, Blom J, Tormey DC.
    Oncology; 1974 Dec 01; 29(2):139-46. PubMed ID: 4525917
    [No Abstract] [Full Text] [Related]

  • 10. Case 6-1985: progressive pneumonitis after chemotherapy for breast cancer.
    N Engl J Med; 1985 Jul 04; 313(1):49-50. PubMed ID: 3839046
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of advanced breast cancer with a combination of vincristine, fluorouracil, methotrexate, cyclophosphamide and prednisone].
    Rosso R, Brema F, Santi L.
    Tumori; 1973 Jul 04; 59(2):163-5. PubMed ID: 4720643
    [No Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S, Goldstein M.
    Surg Gynecol Obstet; 1973 Jul 04; 137(1):83-6. PubMed ID: 4714324
    [No Abstract] [Full Text] [Related]

  • 13. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
    Nüvemann M, Fernholz HJ, Frik W.
    Med Klin; 1976 Oct 01; 71(40):1676-83. PubMed ID: 184372
    [Abstract] [Full Text] [Related]

  • 14. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT.
    Cancer Treat Rep; 1978 Mar 01; 62(3):449-50. PubMed ID: 348314
    [No Abstract] [Full Text] [Related]

  • 15. Acute leukemia complicating metastatic breast cancer.
    Davis HL, Prout MN, McKenna PJ, Cole DR, Korbitz BC.
    Cancer; 1973 Mar 01; 31(3):543-6. PubMed ID: 4511910
    [No Abstract] [Full Text] [Related]

  • 16. Chemotherapy-associated pulmonary toxic reactions during treatment for breast cancer.
    White DA, Orenstein M, Godwin TA, Stover DE.
    Arch Intern Med; 1984 May 01; 144(5):953-6. PubMed ID: 6608932
    [Abstract] [Full Text] [Related]

  • 17. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S.
    Cancer; 1977 Aug 31; 40(2):625-32. PubMed ID: 329975
    [Abstract] [Full Text] [Related]

  • 19. Breast cancer 1984: state of the art.
    Sledge GW.
    Indiana Med; 1984 Dec 31; 77(12):935-9. PubMed ID: 6394645
    [No Abstract] [Full Text] [Related]

  • 20. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.
    Steward AM, Nixon D, Zamcheck N, Aisenberg A.
    Cancer; 1974 May 31; 33(5):1246-52. PubMed ID: 4823478
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.